U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891182) titled 'VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study' on Oct. 14.
Brief Summary: The purpose of this study is to determine if injections of aflibercept into the eye given at the end of the Ahmed tube surgery as well as at postoperative months one and two would improve eye pressure control compared to standard surgery with no aflibercept.
Study Start Date: Dec., 2026
Study Type: INTERVENTIONAL
Condition:
Glaucoma
Intervention:
DRUG: Aflibercept Injection
Aflibercept 8 mg will be administered intravitreally at three time points: immediately after Ahmed tube surgery, at postoperative month 1, and at postop...